pI: 4.7907 |
Length (AA): 413 |
MW (Da): 47536 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_152949)
Species | Accession | Gene Product |
---|---|---|
Homo sapiens | ENSG00000005001 | protease, serine, 22 |
Mus musculus | ENSMUSG00000045027 | protease, serine 22 |
Schistosoma japonicum | Sjp_0204220 | ko:K09637 transmembrane protease, serine 6, putative |
Schistosoma mansoni | Smp_103680 | subfamily S1A unassigned peptidase (S01 family) |
Schmidtea mediterranea | mk4.010080.00 | Subfamily S1A unassigned peptidase |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Alpha-chymotrypsin | 245 aa | 30.4% | 240 aa | Compounds | References |
Canis lupus familiaris | Tryptase | 275 aa | 30.1% | 259 aa | Compounds | References |
Rattus norvegicus | Tryptase alpha/beta-1 | 273 aa | 31.1% | 251 aa | Compounds | References |
Rattus norvegicus | Elastase 2A | 271 aa | 30.7% | 251 aa | Compounds | References |
Sus scrofa | Glandular kallikrein | 246 aa | 29.8% | 258 aa | Compounds | References |
Rattus norvegicus | Mast cell protease 3 | 247 aa | 20.9% | 215 aa | Compounds | References |
Sus scrofa | Elastase 1 | 266 aa | 26.5% | 257 aa | Compounds | References |
Bos taurus | Trypsin I | 246 aa | 30.6% | 242 aa | Compounds | References |
Oryctolagus cuniculus | Thrombin | 235 aa | 31.1% | 238 aa | Compounds | References |
Sus scrofa | Trypsin | 231 aa | 28.9% | 242 aa | Compounds | References |
Sus scrofa | Elastase 2A | 269 aa | 31.8% | 267 aa | Compounds | References |
Canis lupus familiaris | Coagulation factor X | 159 aa | 27.3% | 161 aa | Compounds | References |
Sus scrofa | Pancreatic elastase | 269 aa | 31.8% | 267 aa | Compounds | References |
Bos taurus | Trypsin II | 247 aa | 29.8% | 242 aa | Compounds | References |
Bos taurus | Beta-chymotrypsin | 245 aa | 30.4% | 240 aa | Compounds | References |
Rattus norvegicus | Trypsin II | 246 aa | 30.6% | 242 aa | Compounds | References |
Rattus norvegicus | Anionic trypsin-1 | 246 aa | 31.0% | 242 aa | Compounds | References |